CFRA analyst Wan Nurhayati downgraded Novo Nordisk (NYSE: NVO) from Hold to Sell with a price target of $38.00.

For an analyst ratings summary and ratings history on Novo Nordisk click here. For more ratings news on Novo Nordisk click here.

Shares of Novo Nordisk closed at $39.80 yesterday.